Our results showed a gene alteration frequency of ≥25.00%, ≥25.00%, and ≥44.44% for the 50 most frequently altered neighboring genes of BRD2, BRD3, and BRD4, respectively, in patients with ACC. This evidence concerns the gene BRD4 and adrenal cortex carcinoma.